Estradiol Patch, Extended Release
Product Images NDC 70710-1191

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 70710-1191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (51a2adf6 A381 42cb Bf3e 8c83a7cfe738 01)

Chemical structure of estradiol illustrating its steroid backbone with hydroxyl (OH) groups and multiple hydrogen atoms indicated. The diagram shows the characteristic fused ring structure of the molecule with methyl and hydroxyl substituents.*

FDA Label Image

Tds-layers (51a2adf6 A381 42cb Bf3e 8c83a7cfe738 02)

An illustration showing the three layers of an Estradiol transdermal patch: (1) Backing, (2) Adhesive containing Estradiol, and (3) Protective liner. The diagram visually separates these layers with distinct patterns and labels each accordingly.*

FDA Label Image

Figure-1 (51a2adf6 A381 42cb Bf3e 8c83a7cfe738 03)

A line graph showing concentration (pg/mL) over time (days) for Estradiol transdermal patches at different daily doses: 0.1 mg/day, 0.075 mg/day, 0.05 mg/day, and 0.0375 mg/day. Concentrations increase initially and then fluctuate or stabilize across approximately 4 days for each dose group.*

FDA Label Image

Estra-tw-05 (51a2adf6 A381 42cb Bf3e 8c83a7cfe738 04)

A bar chart comparing mean (SD) reduction from baseline at Weeks 4, 8, and 12 between Estradiol Transdermal System 0.0375 mg/day (Twice-Weekly) and placebo. The Estradiol group consistently shows greater reductions than placebo, with statistical significance indicated at each time point.*

FDA Label Image

Estra-tw-06 (51a2adf6 A381 42cb Bf3e 8c83a7cfe738 05)

A line graph showing the percent change from baseline over treatment duration in weeks (26, 52, 78, 104) for Estradiol Transdermal System at doses 0.1, 0.05, 0.0375, 0.025 mg/day (twice-weekly) compared to placebo. Higher doses show greater increases, while placebo shows a decrease over time.*

FDA Label Image

Estra-tw-07 (51a2adf6 A381 42cb Bf3e 8c83a7cfe738 06)

A line graph showing the percent change from baseline over treatment duration (weeks 26 to 104) for Estradiol Transdermal System at doses 0.1, 0.05, 0.0375, and 0.025 mg/day (twice-weekly) compared to placebo. The graph includes data points for each dose and placebo, with statistical significance markers (p<0.05) indicating comparisons to placebo.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 2)

A dosing schedule panel for Estradiol Transdermal System instructing to change the patch only on two specific days per week. Various pairs of days are listed as checkboxes, including combinations like Sun/Wed and Mon/Thu. The panel is designed to aid patients in timing their patch replacements properly.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 3)

An instructional illustration showing a hand applying a rectangular transdermal patch to the abdominal area. The diagram demonstrates correct placement of the Estradiol extended-release patch on the skin for transdermal administration.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 4)

The image shows a white rectangular transdermal patch of Estradiol extended release. The patch has a small, central marking that resembles the letter 'T'. There is no visible text or other markings on the patch. This product is manufactured by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 5)

An instructional illustration showing two hands applying or handling a small square patch, likely representing the use of a transdermal patch dosage form such as the Estradiol extended-release patch. One hand holds the patch, while the other appears to be peeling it from a backing.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 6)

An instructional line drawing showing two hands peeling apart a backing layer from a rectangular adhesive patch, illustrating the preparation step for applying a transdermal Estradiol patch. No text or dosing details are visible.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 7)

Illustration showing a hand applying a rectangular transdermal patch to the skin, demonstrating the correct placement of the Estradiol extended-release patch on the body.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 8)

An instructional line drawing showing two hands; one hand is holding a ring-shaped patch with a central hole, while the other hand is about to apply or place the patch on the first hand's finger. The illustration appears to demonstrate the application or handling of a transdermal patch dosage form.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 9)

An instructional illustration showing hands applying a small square patch to a finger. The image likely depicts the application method for a transdermal medication patch, consistent with the use of estradiol extended release patches.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 10)

An instructional line drawing illustrating the application of a transdermal patch on the back of a hand, likely for a medication such as Estradiol PATCH, EXTENDED RELEASE.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 11)

An illustration showing a hand applying a rectangular estradiol transdermal patch to the lower abdomen area of a human torso. The image demonstrates the placement site for the extended-release patch delivery.*

FDA Label Image

0.025 mg/day (51a2adf6 A381 42cb Bf3e 8c83a7cfe738 07)

Packaging label for Estradiol Transdermal System, USP (Twice-Weekly) delivering 0.025 mg/day. The carton includes patient instructions for use and indicates the product contains 8 systems. Labeler is Zydus Pharmaceuticals USA Inc. The label features the NDC 70710-1191-8, dosing information, storage instructions, and manufacturer details including Zydus Lifesciences Ltd., India.*

FDA Label Image

0.0375 mg/day (51a2adf6 A381 42cb Bf3e 8c83a7cfe738 08)

Packaging label for Estradiol Transdermal System, USP (Twice-Weekly) patch delivering 0.0375 mg/day. The box includes 8 extended-release transdermal patches. Labeled by Zydus Pharmaceuticals USA Inc., the label provides patient instructions for application and storage information. The NDC is 70710-1192-8 and the product is for prescription use only.*

FDA Label Image

0.05 mg/day (51a2adf6 A381 42cb Bf3e 8c83a7cfe738 09)

Packaging label for Estradiol Transdermal System, USP (Twice-Weekly) delivering 0.05 mg/day. The package contains 8 systems of the extended-release transdermal patch for topical application. The label shows patient instructions for use and is manufactured by Zydus Pharmaceuticals USA Inc. The label indicates storage instructions and includes barcode and product identification details.*

FDA Label Image

0.075 mg/day (51a2adf6 A381 42cb Bf3e 8c83a7cfe738 10)

Packaging label for Estradiol Transdermal System USP Twice-Weekly patch delivering 0.075 mg/day. The box indicates it contains 8 systems, with application instructions and storage information. Manufactured by Zydus Pharmaceuticals USA Inc., the label emphasizes the 0.075 mg/day delivery strength and includes NDC 70710-1194-8.*

FDA Label Image

0.1 mg/day (51a2adf6 A381 42cb Bf3e 8c83a7cfe738 11)

Packaging label for Estradiol Transdermal System, USP (Twice-Weekly) delivering 0.1 mg/day. The carton indicates it includes 8 systems and is labeler by Zydus Pharmaceuticals USA Inc. Directions for use and storage instructions are printed on the box along with a UPC barcode and the NDC 70710-1195-8. The label highlights the transdermal patch dosage form and the frequency of twice-weekly application.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.